The Effect of Maternal Vitamin D Concentration on Fetal Bone
Overview
Authors
Affiliations
Context: Vitamin D deficiency during pregnancy may be associated with suboptimal fetal growth, but direct evidence is lacking.
Objectives: The aim of the study was to validate a method for fetal femur volume (FV) measurement using three-dimensional ultrasound and to detect correlations between FV and maternal vitamin D concentration.
Design, Setting, And Participants: A novel method for assessing FV consists of three ultrasound measurements-femur length, proximal metaphyseal diameter (PMD), and midshaft diameter-and a volume equation; this was validated by comparing ultrasound to computed tomography measurements in six pregnancies after mid-trimester termination. This method was then applied in a cohort of healthy pregnant women participating in the Southampton Women Survey. Fetal three-dimensional ultrasound and maternal 25-hydroxyvitamin D [25(OH)D] levels were performed at 34 wk; dual-energy x-ray absorptiometry of the newborn was performed shortly after birth. Univariate and multiple linear regression analyses were performed between maternal characteristics and fetal outcomes.
Main Outcome Measures: We performed ultrasound measurements of the fetal femur.
Results: In 357 pregnant participants, serum 25(OH)D correlated significantly with FV (P = 0.006; r = 0.147) and PMD (P = 0.001; r = 0.176); FV also demonstrated positive univariate correlations with maternal height (P < 0.001; r = 0.246), weight (P = 0.003; r = 0.160), triceps skinfold thickness (P = 0.013; r = 0.134), and a borderline negative effect from smoking (P = 0.061). On multiple regression, independent predictors of FV were the maternal height and triceps skinfold thickness; the effect of 25(OH)D on FV was attenuated, but it remained significant for PMD.
Conclusion: Using a novel method for assessing FV, independent predictors of femoral size were maternal height, adiposity, and serum vitamin D. Future trials should establish whether pregnancy supplementation with vitamin D is beneficial for the fetal skeleton, using FV and PMD as fetal outcome measures.
Vitamin D supplementation for women during pregnancy.
Palacios C, Kostiuk L, Cuthbert A, Weeks J Cochrane Database Syst Rev. 2024; 7():CD008873.
PMID: 39077939 PMC: 11287789. DOI: 10.1002/14651858.CD008873.pub5.
Deepa R, van Schayck O, Babu G Front Nutr. 2024; 11:1352617.
PMID: 38887504 PMC: 11180835. DOI: 10.3389/fnut.2024.1352617.
Molecular pathways in placental-fetal development and disruption.
Adibi J, Zhao Y, Koistinen H, Mitchell R, Barrett E, Miller R Mol Cell Endocrinol. 2023; 581:112075.
PMID: 37852527 PMC: 10958409. DOI: 10.1016/j.mce.2023.112075.
Ahmed A, Saleem M, Saeed F, Afzaal M, Imran A, Akram S Food Sci Nutr. 2023; 11(9):5004-5027.
PMID: 37701195 PMC: 10494632. DOI: 10.1002/fsn3.3519.
Lu Y, Zhang X, Wu S, Zhang S, Tan J Front Nutr. 2022; 9:973332.
PMID: 36159484 PMC: 9493010. DOI: 10.3389/fnut.2022.973332.